
Source Biopharmadive.com: With positive results from a mid-stage study in hand, Sanofi is pushing an experimental multiple sclerosis drug into an extensive late-stage research program comprised of four studies scheduled to begin in the middle of this year. More details from the Phase 2b study will be presented at an upcoming medical meeting, according to Sanofi…. Read more »